Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | NMT1 | P30419 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25429967 | 1.00 | L3MBTL1 (0.33) | L3MBTL1ADORA2AADORA2BNMT1 | |
| SCHEMBL2143901 | 0.82 | ADORA2A (0.47) | L3MBTL1ADORA2AADORA2BNMT1 | |
| SCHEMBL31559591 | 0.82 | ADORA2A (0.47) | L3MBTL1ADORA2AADORA2BNMT1 | |
| SCHEMBL27170063 | 0.81 | ADORA2A (0.37) | ADORA2AADORA2B | |
| SCHEMBL29985301 | 0.81 | ADORA2A (0.37) | ADORA2AADORA2B | |
| SCHEMBL30791764 | 0.79 | NMT1 (0.37) | ADORA2AADORA2BNMT1 | |
| SCHEMBL24252947 | 0.79 | NMT1 (0.37) | ADORA2AADORA2BNMT1 | |
| SCHEMBL31393091 | 0.79 | LMNA (0.34) | ADORA2AADORA2B | |
| SCHEMBL26123446 | 0.78 | CYP11B1 (0.34) | — | |
| SCHEMBL20520461 | 0.74 | PDK1 (0.36) | L3MBTL1NMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122055363-A | Compounds and methods for modulating splicing | 雷密克斯医疗公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4724438-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | Remix Therapeutics Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024259015-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| EP-4221703-A1 | HSD17B13 INHIBITORS AND USES THEREOF | FL2022-001, Inc. (US) | 2023-08-09 | — | — | EP | disclosed |
| WO-2022072517-A1 | HSD17B13 INHIBITORS AND USES THEREOF | METACRINE, INC. (US) | 2022-04-07 | — | — | WO | disclosed |